Mika Lehto
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF. (NCT02909166) | Mika Lehto | 2012-01-01 |
Track Mika Lehto automatically
Every clearance here is in the API, with alerts when new ones post.